Lu Han
Critic · DISC type CLu Han is the Co-founder and CEO of Imviva Biotech, a clinical-stage company pioneering allogeneic CAR-T cell therapies. With a background in private equity from Morgan Stanley and an MSc from LSE, he now leads the development of "off-the-shelf" treatments for autoimmune diseases and cancer, backed by top investors.
Outside of his executive role, Lu demonstrates a personal commitment to advancing medical research. He has participated in fundraising events like the ASH Foundations morning run, showing his support for progress in blood disease research, a field directly related to his companys work.
His company, formerly Bioheng Therapeutics, rebranded to Imviva Biotech to reflect its strategic global expansion.
Read the full overview →How Lu shows up
They don’t appreciate bells and whistles unless backed by data. They prefer to analyze logically and value objective facts over emotions. They like to take decisions independently and do not seek others' support often.
Topics Lu cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.